 |
Previous Article | Next Article 
The Journal of Neuroscience, June 1, 2001, 21(11):3764-3770
Bipartite Interaction between Neurofibromatosis Type I Protein
(Neurofibromin) and Syndecan Transmembrane Heparan Sulfate
Proteoglycans
Yi-Ping
Hsueh1, 2,
Anne
M.
Roberts3,
Manuela
Volta3,
Morgan
Sheng2, and
Roland G.
Roberts3
1 Institute of Molecular Biology, Academia Sinica,
Taipei, Taiwan, 115, Republic of China, 2 Howard Hughes
Medical Institute and Department of Neurobiology, Massachusetts General
Hospital and Harvard Medical School, Boston, Massachusetts 02114, and
3 Division of Medical and Molecular Genetics, Guy's,
King's, and St. Thomas's Medical School, London SE1 9RT, United
Kingdom
 |
ABSTRACT |
The neurofibromatosis type 1 (NF1) gene encodes a large tumor
suppressor protein (neurofibromin). Although it is known to possess Ras
GTPase-activating protein (GAP) activity, the cellular role of
neurofibromin remains unclear. Here we used yeast two-hybrid screening
to identify neurofibromin-interacting proteins. Syndecan-2, a
transmembrane heparan sulfate proteoglycan (HSPG), was isolated as a
binding partner for two distinct regions of the neurofibromin protein.
We subsequently found that neurofibromin can bind all four mammalian
syndecans. NF1 interaction requires the transmembrane domain and a
membrane-proximal region of the cytoplasmic tail of syndecan, but not
the C terminus of syndecan known to bind to CASK, a
membrane-associated guanylate kinase (MAGUK). Neurofibromin, syndecans,
and CASK have overlapping subcellular distributions in axons and
synapses of neurons, as shown by biochemical fractionation and
immunostaining. Moreover, neurofibromin exists in a complex with
syndecan and CASK in vivo, as evidenced by their
coimmunoprecipitation from rat brain. Our findings suggest that
interaction with different members of the syndecan family may be a
mechanism for localizing neurofibromin to specialized domains of the
plasma membrane.
Key words:
NF1; RasGAP; postsynaptic density; axon; yeast two-hybrid
analysis; CASK/LIN-2
 |
INTRODUCTION |
Neurofibromatosis type I (NF1) is a
common dominantly inherited neurocutaneous disorder characterized by
benign and malignant tumors of the nervous system. The disease
phenotype seems to be mainly a manifestation of abnormal proliferation
and/or differentiation in cells of neural crest origin. The NF1 gene is
widely expressed in many tissues but at particularly high levels in the
CNS and peripheral nervous system (PNS; Daston et al., 1992 ; Nordlund et al., 1993 ). NF1 encodes a large protein of 2818 amino acids (aa)
known as neurofibromin; most germline mutations in the NF1 gene are
predicted to result in a truncated and probably nonfunctional protein.
A central 350-amino-acid region of neurofibromin (the GAP-related
domain or GRD) is homologous to known GTPase-activating proteins
(GAPs). This GRD has been shown to act as a GAP for the Ras family of
small GTPases that regulate cell growth and differentiation (Ballester
et al., 1990 ; Martin et al., 1990 ). Homozygous mice with targeted
disruption of the NF1 gene show lethal developmental abnormalities,
whereas heterozygotes are predisposed to the development of various
tumor types (Brannan et al., 1994 ; Jacks et al., 1994 ; Cichowski et
al., 1999 ; Vogel et al., 1999 ). It is assumed that neurofibromin acts
as a tumor suppressor by inhibiting the activity of Ras. In addition,
Drosophila neurofibromin has been shown to be a regulator of
the cAMP pathway and to be required for learning (Guo et al., 1997 ,
2000 ) However, the precise cellular roles of neurofibromin remain
unclear. To gain potential clues to neurofibromin function, we used the
yeast two-hybrid system to search for neurofibromin-interacting proteins. Here, we report that syndecans bind specifically to neurofibromin.
The syndecan family of transmembrane proteins (syndecans 1-4)
constitutes a major class of heparan sulfate proteoglycans (HSPGs) on
the cell surface (for review, see Bernfield et al., 1992 ; David, 1993 ;
Carey, 1997 ). By binding to a variety of secreted
growth/differentiation factors at the cell surface (e.g., fibroblast
growth factor, FGF), syndecan HSPGs are believed to function as
coreceptors in many receptor tyrosine kinase signaling pathways
(Schlessinger et al., 1995 ; Perrimon and Bernfield, 2000 ). In addition,
syndecans bind to extracellular matrix (ECM) proteins such as laminin
and fibronectin and are implicated in cell matrix adhesion, cell
movement, and tissue morphogenesis.
Extracellular domains of syndecans show little homology, but their
short cytoplasmic domains (~30 amino acids) are highly conserved. The
C-terminal four amino acids (-EFYA) shared by all syndecans interact
with CASK (the mammalian LIN-2 homolog) (Cohen et al., 1998 ; Hsueh et
al., 1998 ). In Caenorhabditis elegans the CASK homolog LIN-2
associates with two other PDZ-containing proteins, LIN-7 and LIN-10
(Kaech et al., 1998 ), and all three are required for proper subcellular
localization of the epidermal growth factor (EGF) receptor (Kim, 1997 ).
A homologous ternary complex also exists in mammalian brain (Butz et
al., 1998 ). The mammalian LIN-2/LIN-7/LIN-10 complex probably
also is involved in subcellular targeting of receptors and
cytoskeletal/signaling proteins to specific plasmalemmal domains. In
this report we show that neurofibromin is associated with syndecans and
CASK in brain, thus providing a potential mechanism for localizing
neurofibromin in a molecular microenvironment with specific cell
surface receptors and other signaling molecules.
 |
MATERIALS AND METHODS |
Plasmid construction. Ten segments spanning the human
neurofibromin coding region were amplified by using KlenTaq Advantage DNA polymerase with Marathon Ready human whole brain cDNA (Clontech, Palo Alto, CA) according to the manufacturer's directions. The primers
(sequences available on request) were engineered to contain EcoRI restriction sites. After purification and digestion
these fragments were ligated into EcoRI-digested pBHA and
validated by sequencing. Interstitial deletions of the syndecan-2
coding region were generated by overlap extension that used chimeric primers (sequences available on request). To construct synd-2C and
C-terminal deletion mutants of syndecan-2 for yeast two-hybrid experiments, we PCR-amplified and subcloned the desired
sequences of syndecan-2 into an EcoRI site of vector pGAD10
(Clontech). For construction of GST fusion proteins, the coding regions
of rat syndecan-2 from amino acid residue 33 to the end (residue 211 for GST-synd-2 or residue 145 for GST-synd-2 65) were subcloned into an EcoRI site of vector pGEX-4T-1 (Pharmacia,
Piscataway, NJ).
Antibodies. Rabbit polyclonal antibodies NF1GRP(D) and
NF1GRP(N) were obtained from Santa Cruz (Santa Cruz, CA). Rabbit
antibodies Syn-2C and Syn-3C that recognize the cytoplasmic domain of
syndecan-2 and syndecan-3, respectively, have been described previously
(Hsueh et al., 1998 ; Hsueh and Sheng, 1999 ). The CASK monoclonal
antibody also has been described (Hsueh and Sheng, 1999 ).
Yeast two-hybrid analysis. Yeast two-hybrid analysis was
done by using the L40 yeast strain harboring reporter genes HIS3 and
LacZ under the control of upstream LexA binding sites, as described
previously (Niethammer and Sheng, 1998 ). Bait constructs for each
segment of the neurofibromin coding region were cotransfected into L40
yeast host with pGAD10-cloned cDNA libraries from adult and fetal human
brain (Clontech). This yielded ~4 × 10 6
transformants per bait-library combination. Colonies growing on
histidine-deficient medium (supplemented with 2.5 mM
3-aminotriazole) and yielding a blue color with X-gal were selected for
plasmid recovery.
For liquid culture assay 4 ml of fresh yeast extract, peptone, and
dextrose (YPD) medium was added to 1 ml of overnight culture. The
cultures were incubated at 30°C for a further 3.5 hr with shaking to
reach OD600 = 0.5-0.6. The exact
OD600 was recorded at the time of harvesting of
the cells. Then 1 ml of culture was transferred to a microcentrifuge
tube, washed once with Z buffer, and resuspended in 0.1 ml Z buffer.
Three freeze/thaw cycles were performed by using liquid nitrogen and a
37°C water bath to break down yeast cell walls. Then 0.7 ml of Z
buffer containing 0.0027% (v/v) -mercaptoethanol and 0.16 ml of 4 mg/ml
o-nitrophenyl- -D-galactopyranoside in Z buffer was added to each tube. After development of a yellow color, 0.4 ml of 1 M
Na2CO3 was added to the
tubes. Incubation time was recorded in minutes. After centrifugation at
14,000 rpm for 10 min, the OD420 of the
supernatant was measured. Z buffer without yeast cells was used as a
blank to calibrate the spectrophotometer. -galactosidase units were
calculated as (1000 × OD420)/(incubation time × OD600).
Subcellular fractionation of rat brain extracts. Subcellular
fractions of adult rat brain were prepared as described previously (Huttner et al., 1983 ). Briefly, rat brain Dounce homogenate was centrifuged at 1000 × g to remove nuclei and other
large debris (pelleted in P1). The supernatant was centrifuged at
10,000 × g to obtain a crude synaptosomal fraction
(P2), which subsequently was lysed with hypotonic buffer and
centrifuged at 25,000 × g to pellet a lysed
synaptosomal membrane fraction (LP1). Then the supernatant (LS1) was
centrifuged at 165,000 × g to obtain a crude synaptic
vesicle fraction (LP2) and soluble fraction (LS2). The supernatant
above the P2 fraction was centrifuged at 165,000 × g
to obtain a soluble fraction (S3) and a light membrane fraction (P3).
For developmental studies the P2 fractions were collected from the rats
at the ages of embryonic day 14 (E14) and E18 and postnatal day 3 (P3),
P7, P15, P22, and P42.
GST pulldown assay and coimmunoprecipitation. One-week-old
rat brains were minced and homogenized by Dounce homogenizer in PBS.
Total homogenate was solubilized further with 1% Triton X-100 at 4°C
for 1 hr. For GST pulldown assay the extract was diluted with
sufficient PBS to reduce the final concentration of Triton X-100 to
0.25%. Insoluble material was pelleted by centrifugation at
37,000 × g for 1 hr. Then the supernatant was
incubated with glutathione agarose prebound with GST fusion protein for
~4 hr at 4°C. Unbound proteins were removed by extensive washing,
and the precipitates were analyzed by immunoblotting.
Immunoprecipitation of Triton X-100-solublized extract was performed as
described previously (Hsueh and Sheng, 1999 ), except that antibody
NF1GRP(N) (Santa Cruz) was used for immunoprecipitation and antibody
NF1GRP(D) (Santa Cruz) was used in immunoblotting.
Immunofluorescence staining. Double-label immunofluorescence
that used rat brain with two antibodies raised in the same species was
performed as described previously (Hsueh et al., 1998 ). The procedure
was modified slightly for the staining of cultured hippocampal neurons.
Briefly, cultured neurons were washed three times with PBS and then
fixed with 4% formaldehyde and 4% sucrose in PBS for 10 min. The
cells were treated further with 3%
H2O2 in methanol at
20°C for 15 min. After 30 min of incubation in PBS with 0.5% blocking reagent (TSA fluorescence kit, NEN Life Science Products, Boston, MA) the cells were incubated with 50 ng/ml Syn-2C or Syn-3C antibodies for 2 hr at room temperature or overnight at 4°C. (This concentration of primary antibody gives no detectable signal with conventional secondary antibody immunofluorescence protocols.) After
being washed three times with PBST (PBS containing 0.05% Tween 20),
the cells were incubated with a 1:1000 dilution of biotinylated
anti-rabbit antibody (NEN Life Science Products) at room temperature
for 1 hr and were incubated further with a 1:200 dilution of
streptavidin-conjugated horseradish peroxidase (TSA fluorescence kit,
NEN Life Science Products) for 30 min. Finally, Cy3-conjugated tyramide
(TSA fluorescence kit, NEN Life Science Products) was applied at a
1:100 dilution in amplification diluent (TSA fluorescence kit, NEN Life
Science Products) for 10 min to visualize Syn-2C or Syn-3C staining.
After being washed three times with PBST, these cells were processed
for conventional neurofibromin immunofluorescence staining with
FITC-conjugated secondary antibody as described previously (Hsueh and
Sheng, 1999 ). The results were analyzed with a confocal microscope
(LSM510, Carl Zeiss, Thornwood, NY) with a narrow bandpass filter, and digitized images were processed for publication with Adobe Photoshop (Mountainview, CA).
 |
RESULTS |
Identification of syndecan-2 as a
neurofibromin-binding protein
To identify neurofibromin-interacting proteins, we divided the
neurofibromin coding region into 10 segments, each of which was used as
bait in yeast two-hybrid screens of human brain cDNA libraries.
Specific positives were isolated with three regions of neurofibromin.
The N-terminal region (aa 1-135) interacts with a novel protein with
no obvious similarities to known proteins. Remarkably, two other
regions of neurofibromin, aa 1356-1562 (in the GRD, hereafter called
the J fragment) and aa 2616-2812 (near the C terminus, hereafter
called the P fragment), "fished out" the same interacting clones
from the library (Fig.
1A). The isolated clones contained amino acid residues 87-211 or 97-211 of human syndecan-2, which includes part of the N-terminal extracellular domain,
the entire transmembrane, and cytoplasmic domains of syndecan-2. None
of the other regions of neurofibromin interacted with syndecan-2 in
yeast two-hybrid analysis (data not shown). To narrow down the
syndecan-2 binding site on neurofibromin, we further divided J and P
regions into N- and C-terminal fragments (Jn/Jc and Pn/Pc, respectively). By yeast two-hybrid assays either Jn (aa 1357-1473) or
Pn (aa 2619-2719) regions of neurofibromin were sufficient to interact
with syndecan-2 (Fig. 1A). Thus, two separate parts of neurofibromin can interact with syndecan-2.

View larger version (14K):
[in this window]
[in a new window]
|
Figure 1.
Bipartite interaction of neurofibromin and
syndecan-2. A, Neurofibromin is depicted schematically
at the top; the J and P regions used as baits in yeast
two-hybrid screens are aligned below.
GRD, GAP-related domain. Interactions with human
syndecan-2 are summarized, based on induction of the reporter gene
-galactosidase in yeast two-hybrid assays. B, GST
pulldown assays from brain. Triton X-100 rat brain extract was
incubated with glutathione agarose charged with GST-syndecan-2
(Synd-2) or GST-syndecan-2 mutant lacking the last 65 amino acids (Synd-2 65).
The precipitates were analyzed via immunoblotting by using
neurofibromin (NF1) and syndecan-3
(Synd-3) antibodies.
|
|
To examine the interaction of syndecan-2 and full-length neurofibromin,
we performed GST pulldown assays from rat brain extract. Neurofibromin
was precipitated specifically by a GST fusion of syndecan-2 (amino acid
residue 33-211) containing part of the extracellular domain, plus
complete transmembrane and cytoplasmic domains of rat syndecan-2 (Fig.
1B; data not shown). GST-syndecan-2 65, which
lacks the C-terminal 65 amino acid residues corresponding to the
transmembrane and cytoplasmic domains of syndecan-2, was unable to pull
down neurofibromin from rat brain extract (Fig. 1B).
These biochemical results confirm an interaction between syndecan-2 and native neurofibromin and indicate that the transmembrane and cytoplasmic domains of syndecan are required for neurofibromin binding. GST-syndecan-2 also precipitated syndecan-3 from brain extracts (Fig. 1B), which is consistent with the
known multimerization of syndecans via their transmembrane domains
(Asundi and Carey, 1995 ).
All four mammalian syndecans interact with neurofibromin
Syndecans 1-4 are very similar to each other in their
transmembrane and cytoplasmic domains (60-80% amino acid identity)
but share minimal homology in the extracellular regions (Fig.
2A). Syndecan-1, -3, and -4 also interacted with neurofibromin in the yeast two-hybrid
system (Fig. 2A). The constructs of syndecan-1, -3, and -4 (fused to the GAL4 activation domain) were made to mimic the
syndecan-2 cDNA isolated in the original yeast two-hybrid screen; they
contained 58 residues of the extracellular domain and the entire
transmembrane and cytoplasmic domains (Fig. 2A). Both
J/Jn and P/Pn fragments of neurofibromin were able to interact with
syndecans 1-4 (Fig. 2A), although the interaction
between Jn and syndecan-1 was relatively weak. The same fragments of
neurofibromin did not interact with CASK (data not shown), confirming
the specificity of the interaction.

View larger version (42K):
[in this window]
[in a new window]
|
Figure 2.
Yeast two-hybrid analysis of the
neurofibromin-syndecan interaction. Yeast two-hybrid interactions of
neurofibromin fragments Jn and Pn with syndecans 1-4
(A) or with various syndecan-2 deletion and
substitution mutants (B) were determined by
induction of the reporter gene -galactosidase. A, The
activity of -galactosidase was measured by the time taken for
colonies to turn blue in the X-gal filter assay; +++, 1 hr; ++, 1-3
hr; +, 3-5 hr; , no significant reaction. B,
-galactosidase activity was measured by liquid culture assay. The
numbers represent units of -galactosidase activity
(see Materials and Methods). Neurofibromin fragments were fused to the
LexA DNA binding domain, and syndecans were fused to the GAL-4
transactivation domain. The sequences of syndecans in GAL-4 fusions are
aligned, with deleted sequences left blank. Approximately 50 aa of the
extracellular domain are omitted because of a lack of homology among
different syndecans.
|
|
Both transmembrane and cytoplasmic domains of syndecans are
involved in interaction with neurofibromin
The GST pulldown result (see Fig. 1B) and the
fact that all four syndecans bind to J and P regions of neurofibromin
suggest that the neurofibromin binding site or sites lie within the
highly conserved transmembrane or cytoplasmic regions of syndecans 1-4 (Fig. 2A). We first tested whether the cytoplasmic
domain alone was sufficient for interaction with neurofibromin in yeast
two-hybrid assays. A construct containing the cytoplasmic domain and
four residues of the transmembrane domain of syndecan-2
(synd-2C) showed no interaction with either the Jn or Pn
fragment of neurofibromin (Fig. 2B, second
row). Synd-2C, however, also did not interact with CASK, despite
an intact C terminus containing the CASK PDZ-binding sequence (-EFYA),
suggesting that conformation of this fusion is incorrect. Similarly,
synd-2 TM (a construct deleted specifically for the transmembrane
domain of syndecan-2) was unable to interact with either neurofibromin
or CASK (Fig. 2B, third row). Because the
transmembrane domains of syndecans mediate homo- and
heteromultimerization of syndecans (Asundi and Carey, 1995 ) (Fig.
1B; data not shown), we suspect that association via
the transmembrane domain is essential to present the cytoplasmic domain
appropriately for interaction with neurofibromin and CASK.
The two most highly conserved regions in the cytoplasmic domains of
syndecans are the C terminus (-EFYA) and a membrane-proximal segment
(RMRKKDEGSY). A mutant lacking the last three amino acids of syndecan-2
(synd-2 3) retained strong interaction with the J/Jn and P/Pn
fragments of neurofibromin but lost its interaction with CASK (Fig.
2B). Thus neurofibromin binds to a region of syndecan distinct from the C-terminal CASK binding site. Deletion of the membrane-proximal sequence RKKDEGSY (synd-2 23-30) virtually
abolished syndecan interaction with either Jn and Pn fragments of
neurofibromin (Fig. 2B), reducing the binding
activities to 2 and 0.8% of wild-type, respectively (based on
quantitative -galactosidase assays). This result suggests that the
conserved membrane-proximal sequence RKKDEGSY is indeed important for
interaction with both regions of neurofibromin. We proceeded to
construct double alanine substitution mutants to map the critical
residues. Replacement of RK or KD with alanines (synd-2RK/AA and
synd-2KD/AA) greatly inhibited the interaction with either Jn or Pn
fragments of neurofibromin (Fig. 2B). The effects
were similar to that of the RKKDEGSY deletion mutant (synd-2 23-30).
Mutation of EG to AA (synd-2EG/AA) had a modest effect on the
interaction with neurofibromin, retaining 34 and 85% activity for Jn
and Pn fragments, respectively. Synd-2SY/AA mutation had no effect on
neurofibromin binding. Taken together, the sequence RKKD within the
membrane-proximal region of syndecan appears to be most important for
neurofibromin interaction.
We found, however, that other regions of the cytoplasmic domain of
syndecan-2 also may be involved in the interaction with neurofibromin.
Deletion of the sequence DLGERK (synd-2 17-22) that lies immediately
C-terminal to RKKDEGSY reduced the interactions with Jn and Pn
fragments to 9 and 9.6%, respectively (Fig. 2B). Deletion of the more C-terminal sequence YQKAPT (synd-2 6-11) reduced the activities to 18.4% (for Jn) and 24.9% (for Pn). These results suggest that sequences DLGERK and YQKAPT also contribute to the
interaction with neurofibromin, although they are less important than
the membrane-proximal RKKD motif. This is supported further by the
results from C-terminal truncation mutants. Deleting the last 11 amino
acids of syndecan-2 (synd-2 11) greatly impaired its ability to
associate with neurofibromin (Fig. 2B); further deletion of 20 C-terminal amino acids (synd-2 20) completely
abolished neurofibromin binding (Fig. 2B).
Developmental expression and biochemical fractionation of
neurofibromin, syndecan, and CASK
To study the biochemical interactions of neurofibromin, syndecans,
and CASK in vivo, we first analyzed their expression
patterns in rat brain by immunoblotting (Fig.
3). Expression of neurofibromin protein
was highest in embryonic brain but remained at moderate levels
throughout postnatal development (Fig. 3A). Syndecan-3 (also
known as neuronal or N-syndecan) showed higher expression in embryonic
and early postnatal rat brain than in adult brain (Fig. 3A).
Because our syndecan-1 and -4 antibodies do not work efficiently on
immunoblots of brain, where syndecans are modified highly and
heterogeneously by heparan sulfate, we were unable to assess the levels
of these proteins. CASK is expressed fairly constantly in embryonic and
postnatal brain (Fig. 3A).

View larger version (37K):
[in this window]
[in a new window]
|
Figure 3.
Expression, fractionation, and
coimmunoprecipitation of neurofibromin, syndecan-3, and CASK.
A, Developmental expression profile. Crude synaptosomal
membrane fractions were collected from rat whole brain at different
embryonic (E) and postnatal
(P) ages (days) and immunoblotted for the
indicated proteins. B, Biochemical fractionation. Adult
rat brain homogenate was fractionated by centrifugation (see details in
Materials and Methods). The resulting fractions were immunoblotted for
the indicated proteins. H, Total homogenate;
P1, crude nuclear pellet; S2, supernatant
of P2 pellet; P2, crude synaptosomal membrane;
S3, cytosolic fraction; P3, light
membrane fraction; LS1, supernatant of LP1;
LP1, lysed synaptosomal fraction; LS2,
supernatant of LP2; LP2, crude synaptic vesicle
fraction. C, Presence of neurofibromin in the
postsynaptic density (PSD) fraction of adult rat brain.
Equal protein amounts of crude synaptosomal fraction
(P2), PSD fraction I (PSDI; extracted
once by Triton X-100), and fraction II (PSDII; extracted
twice by Triton X-100) were immunoblotted for neurofibromin, CASK, and
PSD-95. D, Coimmunoprecipitation of neurofibromin,
syndecan, and CASK. Triton X-100-solubilized total homogenate of P7 rat
brain was immunoprecipitated with neurofibromin antibodies or control
rabbit IgG. The precipitates were analyzed by immunoblotting for
neurofibromin, syndecan-3, CASK, and GluR2.
|
|
The subcellular distribution of neurofibromin, syndecan-3, and CASK was
investigated by biochemical fractionation of adult rat brain (Fig.
3B). Neurofibromin is associated predominantly with membrane
fractions, e.g., crude synaptosome (P2), light membrane (P3), lysed
synaptosomal membrane (LP1), and crude synaptic vesicle (LP2)
fractions. Syndecan-3 also is enriched in P2 and LP1. CASK is
distributed more broadly in soluble and membrane fractions. Thus
neurofibromin, syndecan-3, and CASK have nonidentical subcellular distributions overlapping in synaptosome (P2) and synaptosomal membrane
(LP1) fractions.
To explore the possibility that neurofibromin is localized at synapses,
we examined whether neurofibromin cofractionated with the postsynaptic
density (PSD). Indeed, neurofibromin was present in both PSDI
(extracted once with Triton X-100) and PSDII (extracted twice with
Triton X-100) fractions; however, it was not enriched in the PSD like
CASK or PSD-95 (Fig. 3C).
Coimmunoprecipitation of neurofibromin, syndecan-3, and CASK from
rat brain
Because neurofibromin and CASK have different binding sites on
syndecans, these three proteins may form a ternary protein complex. To
test this in vivo, we performed coimmunoprecipitation experiments of rat brain extracts (Fig. 3D). Neurofibromin
antibodies precipitated >50% of neurofibromin from Triton
X-100-solubilized rat brain and coprecipitated ~5-10% of
syndecan-3. In addition, a small fraction of CASK was
coimmunoprecipitated by neurofibromin antibody, indicating the
existence of a native complex containing neurofibromin/syndecan/CASK. A
control integral membrane protein, GluR2, was undetectable in
neurofibromin immunoprecipitates, confirming the specificity of the coimmunoprecipitation.
Overlapping distribution of neurofibromin and syndecan-3
at axons
By immunofluorescence and immunogold EM localization, syndecan-2
is highly enriched at synapses (Hsueh et al., 1998 ), whereas syndecan-3
is concentrated on axons (Fig.
4B; Hsueh and Sheng, 1999 ). Immunostaining of immature cortical neurons in culture (7 DIV)
showed neurofibromin to be distributed widely in neurons, including
axons, dendrites, and cell bodies (Fig. 4A1; data not shown). In mature hippocampal neuronal cultures (20 DIV) neurofibromin antibody revealed staining of both puncta and long processes as well as
diffuse cell body labeling (Fig.
5A1,B1). By
confocal microscopy, neurofibromin staining overlapped with syndecan-3 in axonal processes of both young and mature neuronal culture (Figs.
4E, 5A), whereas in mature hippocampal
neurons it colocalized with syndecan-2 in a punctate synaptic pattern
(Fig. 5B).

View larger version (42K):
[in this window]
[in a new window]
|
Figure 4.
Overlapping distribution of neurofibromin,
syndecan-3, and CASK in axons of 7 DIV cultured cortical neurons.
A-C, Indirect double immunofluorescence staining was
performed with neurofibromin (NF1), syndecan-3
(Synd-3), CASK, and tau antibodies. Each group of images
represents the same field visualized for the protein indicated in
color in each panel. Tau is used as an axonal marker.
D, Neurofibromin antibody was preincubated with
antigenic peptide for 1 hr before being added to the cells. The
neurofibromin staining signal was inhibited completely by competition
of antigenic peptide, suggesting specificity of staining.
E, Confocal images of double immunofluorescence staining
with the use of the TSA fluorescence system (see details in Materials
and Methods). Asterisks in A mark
neurofibromin-positive glial cells at top left
corner.
|
|

View larger version (46K):
[in this window]
[in a new window]
|
Figure 5.
Colocalization of neurofibromin with different
syndecans at different subcellular compartments in mature hippocampal
neuronal cultures. Confocal analysis of indirect immunofluorescence
staining of 20 DIV hippocampal neuronal cultures was performed. Each
group of images represents the same field visualized for the protein
indicated in color in each panel. The fourth
panel of each group is a higher magnification image of the
inset in the third panel.
A, Double staining of neurofibromin and syndecan-3.
B, Double staining of neurofibromin and syndecan-2. TSA
fluorescence system was used for syndecan-2 and syndecan-3 staining
(see details in Materials and Methods).
|
|
We also performed double immunofluorescence staining of rat brain
sections. In concordance with the hippocampal culture results, neurofibromin colocalized with syndecan-3 in axonal pathways such as
the corpus callosum (Fig.
6A). Neurofibromin also
codistributed with syndecan-2 in synapses in the mossy fiber tract of
the hippocampus (Fig. 6B). Taken together with
staining results of cultured neurons, neurofibromin localization
overlaps with different syndecans in different subcellular
compartments, namely with syndecan-2 at synaptic sites and with
syndecan-3 in axons.

View larger version (124K):
[in this window]
[in a new window]
|
Figure 6.
Colocalization of neurofibromin with different
syndecans in different regions of rat brains. A, Double
staining with neurofibromin and syndecan-3 in corpus callosum.
B, Double staining with neurofibromin and syndecan-2 in
region CA3 of hippocampus. MF, Mossy fiber tract. Each
group of images represents the same field visualized for the protein
indicated in color in each panel. TSA fluorescence
system was used for syndecan-2 and syndecan-3 staining (see details in
Materials and Methods).
|
|
 |
DISCUSSION |
Interaction between neurofibromin and the syndecans
To date the only identified biochemical function of neurofibromin
is that of stimulating the GTPase activity of Ras. Here, we report a
novel interaction between neurofibromin and the syndecan family of
transmembrane HSPGs. To our knowledge this represents the first
demonstration of a neurofibromin-interacting protein other than Ras.
Neurofibromin and the syndecans are expressed widely in both neurons
and glia (Daston et al., 1992 ; Nordlund et al., 1993 ; Hsueh et al.,
1998 ; Hsueh and Sheng, 1999 ). Syndecans 1-4 show differential cell
type-specific patterns of expression in the rat CNS (Hsueh and Sheng,
1999 ). For instance, syndecan-2 and -3 are mainly neuronal, whereas
syndecan-4 is expressed selectively in glial cells. Syndecans also are
distributed differentially with respect to subcellular compartment,
syndecan-2 being concentrated in synapses (Hsueh et al., 1998 ) and
syndecan-3 in axons (Hsueh and Sheng, 1999 ). The functional
significance of this differential localization is not clear. However,
because neurofibromin can bind to all four known mammalian syndecans,
it may associate with different syndecan family members in different
cell types or at different subcellular locations in the same way that
CASK can interact with multiple distinct syndecans (Hsueh et al., 1998 , 1999 ).
Remarkably, two widely separated regions in neurofibromin (J and P) can
bind to syndecan. This bipartite interaction could increase the avidity
of binding between neurofibromin and syndecan proteins. By yeast
two-hybrid analysis that used various mutants of syndecan-2, we could
not distinguish between the binding of J and P fragments, suggesting
that the J and P fragments may bind to the same or overlapping regions
of syndecan. Surprisingly, there is no sequence similarity between the
J and P regions. It will be interesting to know whether the J and P
segments lie close to each other in the tertiary or quaternary
structure of neurofibromin and whether they compete or collaborate with
each other for binding to syndecan.
Deletion analysis indicates that both transmembrane and cytoplasmic
domains of syndecan are required for interaction with neurofibromin.
The transmembrane domain of syndecan is unlikely to be the direct
binding site of neurofibromin and previously has been shown to act as a
multimerization domain. Because the cytoplasmic tail of syndecan is
short (~30 amino acids), it is possible that multimerization via the
transmembrane region is required for its presentation in the correct
conformation or stoichiometry for binding to neurofibromin. For
instance, neurofibromin binding may require two or more cytoplasmic
tails of syndecans in close proximity.
Role of the neurofibromin-syndecan interaction
The biochemical fractionation studies indicate that neurofibromin
is associated predominantly with brain membrane fractions (see Fig.
3B). Binding to the transmembrane syndecan proteins provides
a potential mechanism for the membrane association of neurofibromin.
Syndecans are targeted to specific subcellular sites where they
probably are anchored via C terminus-PDZ domain interaction to
scaffold proteins such as CASK (Cohen et al., 1998 ; Hsueh et al., 1998 )
and syntenin (Grootjans et al., 1997 ). PDZ-containing scaffolds
typically assemble large protein complexes at particular sites at the
plasma membrane (Sheng and Sala, 2001 ). CASK also binds to additional
proteins such as Veli/LIN-7 and Mint1/LIN-10, which in turn interact
with other proteins (Bredt, 1998 ). The binding of neurofibromin to
syndecan therefore could target it to a specialized molecular
microdomain organized by CASK and associated proteins at the cell surface.
What is the functional significance of the interaction between
neurofibromin and the syndecans? The exact roles of syndecan HSPGs at
the cell surface are not clearly understood. In general, cell surface
HSPGs are believed to play roles in cell adhesion and intercellular
signaling, often acting as binding sites for growth/differentiation
factors and as coreceptors for conventional receptors (Carey, 1997 ;
Perrimon and Bernfield, 2000 ). Syndecans are implicated in the
maintenance of differentiation and in suppression of tumor growth in
epithelial cells (Leppa et al., 1992 ). In neurons, syndecan-2 promotes
the development of dendritic spines (Ethell and Yamaguchi, 1999 ). By
association with syndecan-2, neurofibromin may contribute to synaptic
RasGAP activity. All of these activities are pertinent to cell
differentiation and proliferation and/or to synaptic plasticity and
hence are relevant to the tumorigenic and learning defect phenotypes of
NF1. The association of neurofibromin with syndecans and CASK suggests
that it may function in an adhesion-signaling complex at the cell
surface, perhaps via the targeting of neurofibromin RasGAP activity to
syndecan-containing microdomains.
 |
FOOTNOTES |
Received Dec. 8, 2000; revised March 5, 2001; accepted March 7, 2001.
This work was supported by the National Neurofibromatosis Foundation
Young Investigator Award (Y.-P.H.), Academia Sinica, Taiwan (Y.-P.H.),
the Special Trustees of Guy's and St. Thomas's Hospitals (A.M.R), and
the Generation Trust (M.V.). R.G.R. was the recipient of a Wellcome
International Fellowship (045735). M.S. is Assistant Investigator of
the Howard Hughes Medical Institute.
Correspondence should be addressed to Morgan Sheng, Howard Hughes
Medical Institute, Massachusetts General Hospital (Wellman 423), 50 Blossom Street, Boston, MA 02114. E-mail: sheng{at}helix.mgh.harvard.edu. Correspondence also may be addressed to Yi-Ping Hsueh, Institute of
Molecular Biology, Academia Sinica, Taipei, Taiwan, 115, Republic of
China. E-mail: yph{at}gate.sinica.edu.tw.
 |
REFERENCES |
-
Asundi V,
Carey D
(1995)
Self-association of N-syndecan (syndecan-3) core protein is mediated by a novel structural motif in the transmembrane domain and ectodomain flanking region.
J Biol Chem
270:26404-26410[Abstract/Free Full Text].
-
Ballester R,
Marchuk D,
Boguski M,
Saulino A,
Letcher R,
Wigler M,
Collins F
(1990)
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
Cell
63:851-859[Web of Science][Medline].
-
Bernfield M,
Kokenyesi R,
Kato M,
Hinkes MT,
Spring J,
Gallo RL,
Lose EJ
(1992)
Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans.
Annu Rev Cell Biol
8:365-393[Web of Science].
-
Brannan C,
Perkins A,
Vogel K,
Ratner N,
Nordlund M,
Reid S,
Buchberg A,
Jenkins N,
Parada L,
Copeland N
(1994)
Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.
Genes Dev
8:1019-1029[Abstract/Free Full Text].
-
Bredt DS
(1998)
Sorting out genes that regulate epithelial and neuronal polarity.
Cell
94:691-694[Web of Science][Medline].
-
Butz S,
Okamoto M,
Südhof TC
(1998)
A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain.
Cell
94:773-782[Web of Science][Medline].
-
Carey D
(1997)
Syndecans: multifunctional cell-surface coreceptors.
Biochem J
327:1-16.
-
Cichowski K,
Shih T,
Schmitt E,
Santiago S,
Reilly K,
McLaughlin M,
Bronson R,
Jacks T
(1999)
Mouse models of tumor development in neurofibromatosis type 1.
Science
286:2172-2176[Abstract/Free Full Text].
-
Cohen AR,
Woods DF,
Marfatia SM,
Walther Z,
Chishti AH,
Anderson JM
(1998)
Human Cask/Lin-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells.
J Cell Biol
142:129-138[Abstract/Free Full Text].
-
Daston M,
Scrable H,
Nordlund M,
Sturbaum A,
Nissen L,
Ratner N
(1992)
The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes.
Neuron
8:415-428[Web of Science][Medline].
-
David G
(1993)
Integral membrane heparan sulfate proteoglycans.
FASEB J
7:1023-1030[Abstract].
-
Ethell I,
Yamaguchi Y
(1999)
Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons.
J Cell Biol
144:575-586[Abstract/Free Full Text].
-
Grootjans J,
Zimmermann P,
Reekmans G,
Smets A,
Degeest G,
Durr J,
David G
(1997)
Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.
Proc Natl Acad Sci USA
94:13683-13688[Abstract/Free Full Text].
-
Guo H,
The I,
Hannan F,
Bernards A,
Zhong Y
(1997)
Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides.
Science
276:795-798[Abstract/Free Full Text].
-
Guo H,
Tong J,
Hannan F,
Luo L,
Zhong Y
(2000)
A neurofibromatosis-1-regulated pathway is required for learning in Drosophila.
Nature
403:895-898[Medline].
-
Hsueh Y-P,
Sheng M
(1999)
Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASK/LIN-2 during rat brain development.
J Neurosci
19:7415-7425[Abstract/Free Full Text].
-
Hsueh Y-P,
Yang F-C,
Kharazia V,
Naisbitt S,
Cohen AR,
Weinberg RJ,
Sheng M
(1998)
Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses.
J Cell Biol
142:139-151[Abstract/Free Full Text].
-
Huttner W,
Schiebler W,
Greengard P,
DeCamilli P
(1983)
Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation.
J Cell Biol
5:1374-1388.
-
Jacks T,
Shih T,
Schmitt E,
Bronson R,
Bernards A,
Weinberg R
(1994)
Tumour predisposition in mice heterozygous for a targeted mutation in NF1.
Nat Genet
7:353-361[Web of Science][Medline].
-
Kaech SM,
Whitfield CW,
Kim SK
(1998)
The LIN-2/LIN-7/LIN-10 complex mediates basolateral membrane localization of the C. elegans EGF receptor LET-23 in vulval epithelial cells.
Cell
94:761-771[Web of Science][Medline].
-
Kim SK
(1997)
Polarized signaling: basolateral receptor localization in epithelial cells by PDZ-containing proteins.
Curr Opin Cell Biol
9:853-859[Web of Science][Medline].
-
Leppa S,
Mali M,
Miettinen H,
Jalkanen M
(1992)
Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells.
Proc Natl Acad Sci USA
89:932-936[Abstract/Free Full Text].
-
Martin G,
Viskochil D,
Bollag G,
McCabe P,
Crosier W,
Haubruck H,
Conroy L,
Clark R,
O'Connell P,
Cawthon R
(1990)
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with Ras p21.
Cell
63:843-849[Web of Science][Medline].
-
Niethammer M,
Sheng M
(1998)
Identification of ion channel-associated proteins using the yeast two-hybrid system.
In: Methods in enzymology (Conn PM,
ed), pp 104-122. New York: Academic.
-
Nordlund M,
Gu X,
Shipley M,
Ratner N
(1993)
Neurofibromin is enriched in the endoplasmic reticulum of CNS neurons.
J Neurosci
13:1588-1600[Abstract].
-
Perrimon N,
Bernfield M
(2000)
Specificities of heparan sulfate proteoglycans in developmental processes.
Nature
404:725-728[Medline].
-
Schlessinger J,
Lax I,
Lemmon M
(1995)
Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors?
Cell
83:357-360[Web of Science][Medline].
-
Sheng M,
Sala C
(2001)
PDZ domains and the organization of supramolecular complexes.
Annu Rev Neurosci
24:1-29[Web of Science][Medline].
-
Vogel K,
Klesse L,
Velasco-Miguel S,
Meyers K,
Rushing E,
Parada L
(1999)
Mouse tumor model for neurofibromatosis type 1.
Science
286:2176-2179[Abstract/Free Full Text].
Copyright © 2001 Society for Neuroscience 0270-6474/01/21113764-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
Y.-L. Lin, Y.-T. Lei, C.-J. Hong, and Y.-P. Hsueh
Syndecan-2 induces filopodia and dendritic spine formation via the neurofibromin-PKA-Ena/VASP pathway
J. Cell Biol.,
June 21, 2007;
177(5):
829 - 841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. S. Ho, F. Hannan, H.-F. Guo, I. Hakker, and Y. Zhong
Distinct Functional Domains of Neurofibromatosis Type 1 Regulate Immediate versus Long-Term Memory Formation
J. Neurosci.,
June 20, 2007;
27(25):
6852 - 6857.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ozawa, N. Araki, S. Yunoue, H. Tokuo, L. Feng, S. Patrakitkomjorn, T. Hara, Y. Ichikawa, K. Matsumoto, K. Fujii, et al.
The Neurofibromatosis Type 1 Gene Product Neurofibromin Enhances Cell Motility by Regulating Actin Filament Dynamics via the Rho-ROCK-LIMK2-Cofilin Pathway
J. Biol. Chem.,
November 25, 2005;
280(47):
39524 - 39533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Gutmann, N. M. Hedrick, J. Li, R. Nagarajan, A. Perry, and M. A. Watson
Comparative Gene Expression Profile Analysis of Neurofibromatosis 1-associated and Sporadic Pilocytic Astrocytomas
Cancer Res.,
April 1, 2002;
62(7):
2085 - 2091.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|